Miraqules co-founder and CEO Sabir Hossain always knew he wanted to follow in his father’s footsteps and run his own business. But he never thought he’d launch a biotech company built around a technology that would have been able to help his father after a near-tragic accident years earlier left him almost bleeding to death.
Bengaluru-based Miraqules developed a nanotechnology in powder form that mimics blood clotting proteins. The blood clotting powder rapidly produces fibrous compounds at room temperature that are a high volume to ratio and can absorb blood quickly when applied.
“This is a product that will give you feedback insta
Continue Reading on TechCrunch
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.